Tag: Xolair

Posted on

Novartis, Roche’s Xolair Help Blunt Severe Milk Allergies in Children – Bloomberg


MedIndia

Novartis, Roche's Xolair Help Blunt Severe Milk Allergies in Children
Bloomberg
Novartis AG (NOVN) and Roche Holding AG (ROG)'s Xolair, a medication used to treat asthma attacks caused by allergens such as pollen and dust mites, helped children overcome milk allergies, a small study …
Xolair May Treat Milk Allergy in KidsWebMD
New treatment may desensitize kids with milk allergies, say researchers at …Scope (blog)
Milk allergy treated with a new desensitization strategyChicago Tribune
U.S. News & World Report
all 44 news articles »

View full post on asthma – Google News

Posted on

Xolair for Seasonal Asthma – About – News & Issues


TheMedGuru

Xolair for Seasonal Asthma
About – News & Issues
There is good news and bad news about Xolair (omalizumab), a newer asthma treat for kids. The good news is that a new study in the New England Journal of Medicine, Randomized Trial of Omalizumab …
Adult Asthma Drug Nearly Eliminates Seasonal Attacks in KidsFox News
Xolair helps reduce seasonal asthma attacks in children–studyTheMedGuru
Xolair Reduces Seasonal Asthma Attacks for Inner City Kids: StudyBusinessWeek
AOL Health –Insidermedicine –Examiner.com
all 96 news articles »

View full post on asthma – Google News

Posted on

Xolair Helps Alleviate Kids’ Seasonal Asthma Flares – AOL Health


MedIndia

Xolair Helps Alleviate Kids' Seasonal Asthma Flares
AOL Health
The Food and Drug Administration recently approved Xolair, a new asthma drug which improves asthma control, nearly eliminates seasonal attacks, and allows a reduction in other asthma symptoms by blocking antibodies …
Adult Asthma Drug Nearly Eliminates Seasonal Attacks in KidsFox News
Xolair Reduces Seasonal Asthma Attacks for Inner City Kids: StudyBusinessWeek
Omalizumab could provide asthma relief for kidsExaminer.com
Pediatric SuperSite –Ice Gems –European Lung Foundation
all 93 news articles »

View full post on asthma – Google News

Posted on

Xolair Reduces Seasonal Asthma Attacks for Inner City Kids: Study – BusinessWeek


LiveScience.com

Xolair Reduces Seasonal Asthma Attacks for Inner City Kids: Study
BusinessWeek
WEDNESDAY, March 16 (HealthDay News) — The injectable medication Xolair reduced asthma symptoms in inner city children with the respiratory condition, and almost eliminated seasonal peaks in asthma attacks, new research shows. …
Study Finds Adult Asthma Drug Dramatically Reduces Seasonal Attacks in KidsMyFox Washington DC
Asthma Worse In Children, Novartis' Xolair RecommendedMedical News Today
New study finds ways to help curb asthma among urban childrenSuperior Telegram
Sify –Clinical Advisor –msnbc.com
all 79 news articles »

View full post on asthma – Google News

Posted on

Asthma Worse In Children, Novartis’ Xolair Recommended – Medical News Today


LiveScience.com

Asthma Worse In Children, Novartis' Xolair Recommended
Medical News Today
A new study suggests that Novartis drug Xolair may aid in the treatment of asthma, the leading cause of chronic illness in children, especially for those living in highly polluted inner-city areas. Asthma affects as many as 10% to 12% of children in …
Omalizumab 'cuts seasonal asthma attacks in youth'Sify
Omalizumab improves asthma control in inner-city childrenClinical Advisor
Drug may relieve kids' asthma in the fallmsnbc.com
MedPage Today –WebMD –U.S. News & World Report
all 50 news articles »

View full post on asthma – Google News

Posted on

Xolair Relieves Kids’ Seasonal Asthma Attacks: Study – WebMD

Xolair Relieves Kids' Seasonal Asthma Attacks: Study
WebMD
March 16, 2011 — The asthma drug Xolair (omalizumab) improves asthma control, nearly eliminates seasonal flare-ups, and allows reductions in the doses of other asthma control medications in children as young as 6, according to a new …
Novartis, Roche's Xolair Helps Stop Asthma Attacks in ChildrenBloomberg

all 2 news articles »

View full post on asthma – Google News

Posted on

Charity angry at NICE decision on Xolair – OnMedica


Daily Mail

Charity angry at NICE decision on Xolair
OnMedica
Omalizumab is licensed as add-on therapy for adults and children aged at least 6 years, who have severe persistent allergic asthma and meet other criteria. …
Asthma drug denied to young childrenExaminer.com
UK's NICE reaffirms decision to deny use of Novartis' asthma drug Xolair for …The Pharma Letter
Under-12s to be denied asthma jab only if they live in EnglandDaily Mail
Telegraph.co.uk –Healthcare Republic –Nursing Times
all 16 news articles »

View full post on asthma – Google News